Visiongain Publishes Cold Compression Therapy Market Report 2020-2030

03 August 2020
Pharma

Visiongain has launched a new pharma report Cold Compression Therapy Market Report 2020-2030: Prospects by Product (OTC products (Sprays, Gels, Roll-ons, Ointments, Creams, Patches, Cold Packs), Prescription Products (Motorized & Non-motorized Devices)), Application (Orthopedic Conditions, Post-operative Therapy, Sports Medicine, Post-trauma Therapy, Distribution channel (Hospital Pharmacy, Retail Pharmacy, eCommerce), and Geography.

Cold compression therapy involves 2 of the principles of R.I.C.E (rest, ice, compression, elevation) to reduce pain & swelling caused to soft tissues by sports/activity injuries. Specifically, this therapy is used to treat sprains, strains pulled muscles & ligaments. Cold compression is a combination of static compression and cryotherapy, typically used after surgical procedures or acute trauma to relieve inflammation & pain.

The global cold compression therapy market is anticipated to grow on account of growing advancements in technology for cold compression therapy, growing instances of arthritis, sports injuries, road accidents and growing ageing population across the globe.

The largest cause of joint diseases is the increasing elderly population. Due to cartilage degeneration and the role of excessive levels of reactive oxygen species, joint diseases are most prevalent among the elderly population. The overall ageing process creates changes in the joint tissues thus leading to osteoarthritis. Osteoarthritis (OA) is an age-related disease that causes the articular cartilage to be degraded & lost. Obesity, joint injury, genetics, & anatomical abnormalities are the major factors responsible for osteoarthritis.

There is a loss in the human body's ability to maintain homeostasis under stressful conditions among the aged population. Therefore, excessive mechanical stress leads to disease development. In contrast, osteoarthritis is mostly seen in the elderly population coupled with a joint injury. According to the CDC, the number of US adults aged 65+ is projected to surpass 95 million. For treating diseases such as arthritis, cold compression therapies are very successful. Thus, growing geriatric population & increased vulnerability to joint diseases are anticipated to boost market growth further.

North America is the largest market capturing the majority of market share owing to factors such as growing healthcare expenditure and growing geriatric population in the United States. However, Asia Pacific cold compression region is anticipated to grow with the highest CAGR over the forecast period owing to the growing patient pool in emerging economies of Japan, China & India. Also, Japan is anticipated to offer lucrative revenue generation avenues for the market players as its population is rapidly aging and its elderly population make up a third of Japan’s population.

Some of the major players operating in this industry are 3M, Beiersdorf, Bio Compression Systems, Breg, Coolsystems (Game Ready), Custom Ice, DJO Global, Hisamitsu Pharmaceutical, Hisamitsu Pharmaceutical, Medline Industries, Inc., Össur, Performance Health, Pfizer, Polar Products, PowerPlay, ROHTO Pharmaceutical Co., Ltd., Romsons Group of Industries, Sanofi, ThermoTek, Unexo Life Sciences Pvt. Ltd. among other prominent players.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

Read

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

Read

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

Read

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever